Acurx Pharmaceuticals Inc Share Price

NASDAQ: ACXP

Small Cap

$4.20

-0.11

(-2.67%)

as on September 16, 2025 at 1:29 am IST

$₹

Acurx Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$4.09
Day's Price Range
$4.26
$4.2
2.62%
Downside
1.43%
Upside
52 Week's Low
52 Week's High
$3.8
52-Week Price Range
$44
$4.2
9.52%
Downside
947.62%
Upside

Acurx Pharmaceuticals Inc share price movements today

Previous Close: $4.31
Open: $4.25
Volume: 326.6K
Day's Low - High: $4.09 - $4.26
52 Week Low - High: $3.8 - $44

Acurx Pharmaceuticals Inc Historical Returns

1 Month Return: -15.66 %
3 Month Return: -29.34 %
1 Year Return: -89.44 %
3 Year Return: -94.47 %
5 Year Return: 0 %

Acurx Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Acurx Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.8M

EPS (TTM)

-6.545

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

204360100.00%

Acurx Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acurx Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Acurx Pharmaceuticals Inc	BUY	$6.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Acurx Pharmaceuticals Inc Stock including INR - Dollar returns

The Acurx Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Acurx Pharmaceuticals Inc investment value today

Current value as on today

₹15,279

Returns

₹84,721

(-84.72%)

Returns from Acurx Pharmaceuticals Inc Stock

₹89,706 (-89.71%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Acurx Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Acurx Pharmaceuticals Inc. Average target price of $61.7

Acurx Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Acurx Pharmaceuticals Inc.

What analysts predicted

93.19%UPSIDE

Target Price

$61.7

Current Price

$4.2

Analyzed by

8 Analysts

Target

$61.70

Acurx Pharmaceuticals Inc target price $61.7, a slight upside of 93.19% compared to current price of $4.2. According to 8 analysts rating.

Acurx Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Acurx Pharmaceuticals Inc Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-42% versus previous 30 day period

Acurx Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-3	-3	-5	-4	-4	-2	-2	-2	-2
EBITDA	-2	-3	-3	-5	-4	-4	-2	-2	-2	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-3	-3	-5	-4	-4	-2	-2	-2	-2
Income Tax Expense	0	3,441	0	0	-4	-4	-	4	-	-
Net Income	-2	-3	-3	-5	-4	-4	-2	-2	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Acurx Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	-5	-4	-12	-12	-14	-14
EBITDA	-5	-4	-12	-12	-14	-14
Interest Expense	-	-	0	0	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-5	-4	-12	-12	-14	-14
Income Tax Expense	0	0	0	0	0	-14,088
Net Income	-5	-4	-12	-12	-14	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Acurx Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-3	-5	-4	-4	-2	-2	-2	-2
Operating Cash Flow	-1	-2	-4	-3	-2	-2	-2	-2	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	-	4	4	0	1	0	2	3
Change in Cash	1	-2	0	1	-2	0	-2	0	1

Acurx Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-4	-12	-12	-14	-14
Operating Cash Flow	-3	-5	-7	-9	-10
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	4	14	3	8	6
Change in Cash	0	9	-3	-1	-3

Global Institutional Holdings in Acurx Pharmaceuticals Inc

Funds	Holdings
Sabby Management LLC	6.65%
Vanguard Group Inc	1.72%
Prospect Financial Services Llc	1.19%
Geode Capital Management, LLC	0.56%
Morgan Stanley - Brokerage Accounts	0.35%

See all

Insights on Acurx Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 211.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 160.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ACXP stock has moved down by -18.4%

About Acurx Pharmaceuticals Inc

Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. It develops antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its research and development (R&D) pipeline include antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE), drug-resistant Streptococcus pneumoniae (DRSP) and B. anthracis (anthrax; a Bioterrorism Category A Threat-Level pathogen). Its lead antibiotic candidate, ibezapolstat targets the pol IIIC enzyme.

Organisation	Acurx Pharmaceuticals Inc
Headquarters	259 Liberty Avenue, Staten Island, NY, United States, 10305
CEO	Mr. David P. Luci CPA, Esq., J.D.
E-voting on shares	Click here to vote

Key Management of Acurx Pharmaceuticals Inc

Name	Title
Mr. Robert J. DeLuccia	Co-Founder & Executive Chairman
Mr. David P. Luci CPA, Esq., J.D.	Co-Founder, President, CEO, Corporate Secretary & Director
Mr. Robert G. Shawah CPA	Co-Founder & CFO

FAQs

What is Acurx Pharmaceuticals Inc share price today?

Acurx Pharmaceuticals Inc share price today is $4.2 as on September 16, 2025 at 1:29 am IST at the close of the market. Acurx Pharmaceuticals Inc share today touched a day high of $4.26 and a low of $4.09.

What is the 52 week high and 52 week low for Acurx Pharmaceuticals Inc share?

Acurx Pharmaceuticals Inc share touched a 52 week high of $44 on October 4, 2024 and a 52 week low of $3.8 on August 12, 2025. Acurx Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $4.2,which is 90.45% down from its 52 week high and 10.53% up from its 52 week low.

What is Acurx Pharmaceuticals Inc's market capitalisation today?

Acurx Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Acurx Pharmaceuticals Inc Stock (ACXP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Acurx Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acurx Pharmaceuticals Inc Shares that will get you 0.3571 shares as per Acurx Pharmaceuticals Inc share price of $4.2 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Acurx Pharmaceuticals Inc Stock (ACXP) from India?

Indian investors can start investing in Acurx Pharmaceuticals Inc (ACXP) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 12:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Acurx Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 12:44 pm IST). Based on Acurx Pharmaceuticals Inc share’s latest price of $4.2 as on September 16, 2025 at 1:29 am IST, you will get 2.3810 shares of Acurx Pharmaceuticals Inc. Learn more about fractional shares .